289 related articles for article (PubMed ID: 33680977)
21. Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.
Hur YG; Crampin AC; Chisambo C; Kanyika J; Houben R; Ndhlovu R; Mzembe T; Lalor MK; Saul J; Branson K; Stanley C; Ngwira B; French N; Ottenhoff TH; Dockrell HM; Gorak-Stolinska P
Clin Vaccine Immunol; 2014 Feb; 21(2):133-42. PubMed ID: 24285818
[TBL] [Abstract][Full Text] [Related]
22. Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis.
Saleem N; Saba R; Maddika S; Weinstein M
Am J Med Sci; 2017 Apr; 353(4):394-397. PubMed ID: 28317629
[TBL] [Abstract][Full Text] [Related]
23. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
[TBL] [Abstract][Full Text] [Related]
24. Serial testing of Mycobacterium tuberculosis infection in Chinese village doctors by QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold in-Tube and T-SPOT.TB.
Zhang H; Xin H; Wang D; Pan S; Liu Z; Cao X; Wang J; Li X; Feng B; Li M; Yang Q; Zhang M; Jin Q; Gao L
J Infect; 2019 Apr; 78(4):305-310. PubMed ID: 30710557
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan.
Takasaki J; Manabe T; Morino E; Muto Y; Hashimoto M; Iikura M; Izumi S; Sugiyama H; Kudo K
J Infect Chemother; 2018 Mar; 24(3):188-192. PubMed ID: 29108749
[TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Okimoto N; Matsushima T; Kageoka T; Oka M
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1422-6. PubMed ID: 19861017
[TBL] [Abstract][Full Text] [Related]
27.
Mpande CAM; Steigler P; Lloyd T; Rozot V; Mosito B; Schreuder C; Reid TD; Bilek N; Ruhwald M; Andrews JR; Hatherill M; Little F; Scriba TJ; Nemes E
Front Immunol; 2021; 12():712480. PubMed ID: 34526988
[TBL] [Abstract][Full Text] [Related]
28. Interferon-Gamma Release Assay is Not Appropriate for the Diagnosis of Active Tuberculosis in High-Burden Tuberculosis Settings: A Retrospective Multicenter Investigation.
Kang WL; Wang GR; Wu MY; Yang KY; Er-Tai A; Wu SC; Geng SJ; Li ZH; Li MW; Li L; Tang SJ
Chin Med J (Engl); 2018 Feb; 131(3):268-275. PubMed ID: 29363640
[TBL] [Abstract][Full Text] [Related]
29. Clinical presentations of nontuberculous mycobacteria as suspected and drug-resistant tuberculosis: Experience from a tertiary care center in Eastern India.
Das S; Mishra B; Mohapatra PR; Preetam C; Rath S
Int J Mycobacteriol; 2022; 11(2):167-174. PubMed ID: 35775549
[TBL] [Abstract][Full Text] [Related]
30. [Clinical characteristics and drug susceptibility test of nontuberculous mycobacterial lung disease].
Lou H; Sun Q; Gu J; Yang H; Hao XH; Xiao HP; Sha W
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):901-906. PubMed ID: 31826533
[No Abstract] [Full Text] [Related]
31. Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea.
Yoon HJ; Choi HY; Ki M
BMC Infect Dis; 2017 Jun; 17(1):432. PubMed ID: 28619015
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection.
Soysal A; Torun T; Efe S; Gencer H; Tahaoglu K; Bakir M
Int J Tuberc Lung Dis; 2008 Jan; 12(1):50-6. PubMed ID: 18173877
[TBL] [Abstract][Full Text] [Related]
33. [Biologics and mycobacterial diseases].
Tsuyuguchi K; Matsumoto T
Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
[TBL] [Abstract][Full Text] [Related]
34. Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay.
Ra SW; Lyu J; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
Int J Tuberc Lung Dis; 2011 May; 15(5):635-40. PubMed ID: 21756514
[TBL] [Abstract][Full Text] [Related]
35. Establishment and validation of a predictive model for nontuberculous mycobacterial infections in acid-fast bacilli smear-positive patients.
Chen X; Zhang Y; Xu J; Li H
Clin Respir J; 2021 Nov; 15(11):1147-1157. PubMed ID: 34265149
[TBL] [Abstract][Full Text] [Related]
36. Utility of interferon-γ release assay results to monitor anti-tubercular treatment in adults and children.
Chiappini E; Fossi F; Bonsignori F; Sollai S; Galli L; de Martino M
Clin Ther; 2012 May; 34(5):1041-8. PubMed ID: 22512899
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
[TBL] [Abstract][Full Text] [Related]
38. Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment.
Gopalaswamy R; Shanmugam S; Mondal R; Subbian S
J Biomed Sci; 2020 Jun; 27(1):74. PubMed ID: 32552732
[TBL] [Abstract][Full Text] [Related]
39. Routinely detected indicators in plasma have a predictive effect on the identification of HIV-infected patients with non-tuberculous mycobacterial and tuberculous infections.
Cai RT; Yu FX; Tao Z; Qian XQ; Chen J; Lu HZ
Infect Dis Poverty; 2017 Nov; 6(1):132. PubMed ID: 29092717
[TBL] [Abstract][Full Text] [Related]
40. Profile of patients with pulmonary non-tuberculous mycobacterial disease mimicking pulmonary tuberculosis.
Gomathy NS; Padmapriyadarsini C; Silambuchelvi K; Nabila A; Tamizhselvan M; Banurekha VV; Lavanya J; Chandrasekar C
Indian J Tuberc; 2019 Oct; 66(4):461-467. PubMed ID: 31813432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
